Next Quarterly Earnings
Monday, November 9, 2026
Expected
Apogee Therapeutics
Apogee Therapeutics is a leading U.S. biotechnology company specializing in the development of advanced biologic therapies for immunological and inflammatory diseases. Through innovative protein engineering technologies, the company targets and addresses key drivers of inflammatory processes.
Frequently asked questions
When did Apogee Therapeutics last report quarterly earnings?
Apogee Therapeutics last reported quarterly earnings on 8/10/2026 (Q2 2026). Earnings per share (EPS) came in at -1.14 USD.
How often has Apogee Therapeutics beaten expectations?
Apogee Therapeutics has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
How do I add the Apogee Therapeutics earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
In the earnings calendar
Earnings statistics
Estimates vs. results
3/5
Quarters above estimates
60%
Beat rate
-0.9%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Apogee Therapeutics
Country
🇺🇸
More Financial Information